BRF
CGTX icon

B. Riley Financial’s Cognition Therapeutics CGTX Stock Holding History

B. Riley Financial’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-30,904
Closed -$65K – 81
2022
Q2 		$65K Hold
30,904
– – 0.01% 51
2022
Q1 		$85K Hold
30,904
– – 0.01% 38
2021
Q4 		$195K Buy
+30,904
New +$301K 0.02% 40

Other funds holding CGTX

PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
PAWC
P.A.W. Capital Greenwich, Connecticut $36.7M AUM 6.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

B. Riley Financial's CGTX Position: Q3 2022 in Review

B. Riley Financial sold out of Cognition Therapeutics (CGTX) in Q3 2022, closing a stake of 30,904 shares — an estimated $65K sold.

B. Riley Financial first reported a position in CGTX in Q4 2021 and held it in 3 quarters. The position peaked at $195K in Q4 2021. 31 funds tracked by Wall St. Rank hold CGTX as of Q3 2022.

  • B. Riley Financial reported no remaining Cognition Therapeutics position as of Q3 2022 after selling out during the quarter.
  • B. Riley Financial sold 30,904 Cognition Therapeutics shares in Q3 2022, an estimated $65K.
  • B. Riley Financial first reported a position in Cognition Therapeutics in Q4 2021 and held it in 3 quarters.
  • B. Riley Financial's Cognition Therapeutics position peaked at $195K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q3 2022.

Based on B. Riley Financial's 13F filing for Q3 2022, filed 9 Nov 2022.